|Articles|June 14, 2007

What's new in Kawasaki disease?

Revised guidelines help evaluate the child who doesn't meet all the classic criteria for KD and provide a framework for long-term management based on the risk of myocardial infarction.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!

Related Content

Vaccines in childhood linked to lower drug-resistant bacteria risk

ByJoshua Fitch, Senior Editor

December 9th 2025

Review finds no systemic risks from aluminum in childhood vaccines

ByMorgan Ebert, Managing Editor

December 9th 2025

Dr. Angeliki Asimaki explains arrhythmogenic cardiomyopathy detection via cheek swab

ByDr, Angeliki Asimaki

December 9th 2025

FDA approves omidubicel-onlv as first HSCT therapy to treat severe aplastic anemia

ByJoshua Fitch, Senior Editor

December 8th 2025

ASH data: Marstacimab improves bleeding outcomes in adolescents, adults with hemophilia A or B

ByJoshua Fitch, Senior Editor

December 8th 2025

Latest CME

Multimedia

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Multimedia

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

In-Person + Virtual Event

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

January 23, 2026

Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Video

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

What's new in Kawasaki disease?

Newsletter

Related Content

Vaccines in childhood linked to lower drug-resistant bacteria risk

Review finds no systemic risks from aluminum in childhood vaccines

Dr. Angeliki Asimaki explains arrhythmogenic cardiomyopathy detection via cheek swab

FDA approves omidubicel-onlv as first HSCT therapy to treat severe aplastic anemia

ASH data: Marstacimab improves bleeding outcomes in adolescents, adults with hemophilia A or B

Latest CME

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

Dr. Angeliki Asimaki explains arrhythmogenic cardiomyopathy detection via cheek swab

Review finds no systemic risks from aluminum in childhood vaccines

ASH data: Marstacimab improves bleeding outcomes in adolescents, adults with hemophilia A or B

ACIP votes to update hepatitis B vaccine recommendation for infants

FDA approves omidubicel-onlv as first HSCT therapy to treat severe aplastic anemia